BioNexus Gene Lab Corp - BGLC Forward P/S Multiple
BioNexus Gene Lab Corp. attracts leading biochemists through investments in science. The forward P/S trend demonstrates the resilience of a business relying on Malaysian laboratories and regional supplies. However, volatility in raw material prices for plastics creates pressure, and the latest mark stands at 0.70, which allows for a real-time assessment of the asset's current margin of safety.
Analytical breakdowns for BioNexus Gene Lab Corp.
- market price and analyst price targets:
- issuer market value details:
- issuer book value statistics:
- debt and liquidity data:
Debt to Equity BioNexus Gene Lab Corp.|BGLC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio BioNexus Gene Lab|BGLC - Aggregate Debt Obligations|Debts to Book Capitalization BioNexus Gene Lab|BGLC - Long-Term Indebtedness|Company Short-Term Debts BioNexus Gene Lab|Quick Liquidity bionexusgenelab.com
- net income and valuation multiples indicators:
BGLC - Company Profit|Projected Future Earnings BioNexus Gene Lab Corp.|BGLC - Market Cap to Earnings|Projected Price to Earnings BioNexus Gene Lab|BGLC - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioNexus Gene Lab|BGLC - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) BioNexus Gene Lab|BGLC - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bionexusgenelab.com|BGLC - Earnings per share growth in current year|Expected earnings per share growth for next year BioNexus Gene Lab Corp.
- sales and revenue indicators:
Summary company analysis:BioNexus Gene Lab Corporation BGLC
Investors must determine the fair value of the asset by comparing current market capitalization with projected sales volumes. Analyzing the expected P/S multiple allows for tracking the compression of revenue valuation relative to market trends, which is critical for BioNexus Gene Lab Corp. (BGLC), as its leadership position in Asian molecular diagnostics and the precision of its genetic tests should support a high business valuation.
Main competitors
Price-to-Projected Revenue Ratio Linde LIN|APD: Market Cap to Projected Revenue|E. I. du Pont de Nemours and Company - Forward P/S Multiple|Market Cap to Future Revenue Ratio IP Corp|PPG (ppg.com) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue DOW|Forward Price-to-Revenue Multiple LYB|Forward P/S Multiple IFF Inc.|Price-to-Projected Revenue Ratio RPM Corp (RPM)|Market Cap to Expected Sales Ratio Entegris Corporation|Suzano S.A. - Forward Price-to-Revenue Multiple|Forward Price to Sales WLK|Albemarle Corporation - Forward P/S Multiple|Projected Price to Revenue Israel Chemicals (ICL)|NEU: Forward P/S Multiple|Market Cap to Future Revenue Ratio Eastman Kodak Chemical (EMN)|Price-to-Projected Revenue Ratio Axalta Coating Systems|Market Cap to Projected Revenue ESI (elementsolutionsinc.com)|Forward P/S Multiple SQM|CE - Market Cap to Future Revenue Ratio|Sensient Corp - Forward Price-to-Revenue Multiple|Forward Price to Sales CBT|HWKN - Price-to-Projected Revenue Ratio|AVNT: Price-to-Projected Revenue Ratio|FUL: Forward P/S Multiple|Methanex Corp (MEOH) - Forward P/S Multiple|WDFC (WD-40 Corp) - Forward P/S Multiple|Price-to-Projected Revenue Ratio CC|Forward Price-to-Revenue Multiple KWR (Quaker Chemical)|PCT (purecycletech.com) - Forward Price to Sales|Forward P/S Multiple ASH (Ashland)|NGVT - Forward Price-to-Revenue Multiple|IOSP - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Minerals Technologies Corp|Daqo New Energy Corp. (DQ) - Price-to-Projected Revenue Ratio|sylvamo.com - Forward Price to Sales|Price-to-Projected Revenue Ratio Huntsman|Albany International Corp - Future Price to Revenue|Forward Price-to-Revenue Multiple CLMT (Calumet Specialty)|Market Cap to Expected Sales Ratio Rogers Materials|Forward P/S Multiple SCL (Stepan Company)|ecovyst.com - Price-to-Projected Revenue Ratio|NeoGenomics - Forward P/S Multiple|Projected Price to Revenue REX American Resources Corp (REX)|ASP Isotopes Corp (ASPI) - Price-to-Projected Revenue Ratio|TROX (Tronox Corp) - Price-to-Projected Revenue Ratio|GSM (Ferroglobe PLC) - Forward P/S Multiple|Forward Price-to-Revenue Multiple wlkpartners.com (WLKP)|Forward P/S Multiple CMP|Forward Price-to-Revenue Multiple Kronos Worldwide Inc KRO|Forward P/S Multiple MATV (Mativ Corp)|Forward Price to Sales LXU|Braskem S.A. - Forward P/S Multiple|Market Cap to Future Revenue Ratio koppers.com|AdvanSix (ASIX) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Orion Engineered Carbons|RYAM (Rayonier Advanced Materials Inc) - Forward P/S Multiple|Aduro Clean Technologies Corp (ADUR) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Magnera Corp (MAGN)|Market Cap to Expected Sales Ratio clearwaterpaper.com|Tredegar - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio CMT (Core Molding Technologies Inc.)|FF - Price-to-Projected Revenue Ratio|Forward Price to Sales FSI (Flexible Solutions)|ALTO (altoingredients.com) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio 5E Advanced Materials, Inc. (FEAM)|TSE (Trinseo S.A.) - Forward P/S Multiple|Price-to-Projected Revenue Ratio ORGN|Forward P/S Multiple NTIC|Market Cap to Expected Sales Ratio LanzaTech Corp|Price-to-Projected Revenue Ratio J-Star Holding YMAT|New Era Energy & Digital Inc (NUAI) - Market Cap to Future Revenue Ratio|BSLK - Price-to-Projected Revenue Ratio|GURE (Gulf Resources Inc.) - Market Cap to Projected Revenue|CNEY: Forward P/S Multiple|Market Cap to Future Revenue Ratio Arcadium Lithium (ALTM)|Forward Price-to-Revenue Multiple DNMR|Market Cap to Projected Revenue GLT (Glatfelter Corp.)|Forward Price-to-Revenue Multiple GRFX (Graphex Group Limited)|Forward P/S Multiple U.S. Silica Holdings, Inc. (SLCA)|Price-to-Projected Revenue Ratio Invizyne IZTC
